title: Diagnosis and pharmacotherapy of conduct disorder.
abstract: 1. There are few double-blind, placebo-controlled studies of the drug treatment of conduct disorders in children and adolescents. 2. The diagnosis of conduct disorders involves a persistent pattern of behavior in which the basic rights of others and standards of society are violated. 3. There is frequent comorbidity associated with conduct disorders including attention-deficit hyperactivity disorder, oppositional defiant disorder, mood disorders and substance abuse. 4. Childhood Conduct disorder is associated with a significant risk for adult psychopathology. 5. A variety of treatment approaches may be employed to combat conduct disorders. 6. The use of neuroleptics, lithium carbonate, stimulants and other agents is reviewed.
authors.affiliation: Department of Psychiatry, Hillside Hospital, Glen Oaks, N.Y.
authors.forename: M R
authors.initials: MR
authors.lastname: Lavin
authors.forename: A
authors.initials: A
authors.lastname: Rifkin
mesh_terms: D000293:Adolescent; D001289:Attention Deficit Disorder with Hyperactivity / Q000175:diagnosis / Q000188:drug therapy; D002648:Child; D002653:Child Behavior Disorders / Q000175:diagnosis* / Q000188:drug therapy*; D002675:Child, Preschool; D006801:Humans; D011619:Psychotropic Drugs / Q000627:therapeutic use
chemical_list: D011619:Psychotropic Drugs